A radical, potentially game-changing technology that threatens to destroy the trillion-dollar, “green energy” grift of the elites. And yet, while it threatens their wealth and power, it could be transformational for both the U.S. economy and your wealth.

One company holds a near-total monopoly on it.

FATE Insider Trading

Insider Trading Chart
Insider Trading History
Frequently Asked Questions
About

Insider Ownership Percentage: 5.04%

Insider Buying (Last 12 Months): $166,023.60

Insider Selling (Last 12 Months): $278,392.35

Fate Therapeutics Insider Trading History Chart

Fate Therapeutics Share Price & Price History

^$3.70

▼ -0.18 (-4.64%)

As of 05/8/2024 01:00 AM ET

Days: 30 | 90 | 365

Bitcoin Rockets To Record High But Buy THIS Instead

From Paradigm Press | Ad

Recently, Bitcoin smashed through its previous record high to hit $72,720. It’s made many, many people very rich. But one cryptocurrency expert and investing millionaire is declaring…

>>Click here to find out what it is.

Fate Therapeutics Insider Trading History

Transaction Date	Insider Name	Title	Buy/Sell	Number of Shares	Average Share Price	Total Transaction	Shares Held After Transaction
1/29/2024	Edward J. Dulac, III	CFO	Sell	1,849	$5.00	$9,245.00	103,926
1/9/2024	Bahram Valamehr	Insider	Sell	11,271	$4.38	$49,366.98	158,069
1/9/2024	Cindy Tahl	General Counsel	Sell	10,874	$4.37	$47,519.38	142,361
1/9/2024	Edward J. Dulac, III	CFO	Sell	7,028	$4.37	$30,712.36	105,775
1/9/2024	J. Scott Wolchko	CEO	Sell	14,391	$4.37	$62,888.67	371,248
12/26/2023	Redmile Group, Llc	Director	Buy	44,630	$3.72	$166,023.60	13,180,388
8/18/2023	Edward J. Dulac, III	CFO	Sell	4,718	$2.80	$13,210.40	119,570
8/4/2023	Yuan Xu	Director	Sell	632	$3.71	$2,344.72	9,302
7/5/2023	Brian T Powl	Insider	Sell	3,854	$4.87	$18,768.98	41,146
7/5/2023	Edward J. Dulac, III	CFO	Sell	5,182	$4.83	$25,029.06	124,288
6/14/2023	Yuan Xu	Director	Sell	3,460	$5.58	$19,306.80	9,934
4/20/2023	Redmile Group, Llc	Director	Buy	20,000	$5.99	$119,800.00	12,879,119
4/18/2023	Yu-Waye Chu	Insider	Sell	2,532	$6.57	$16,635.24	140,676
4/14/2023	Redmile Group, Llc	Director	Buy	25,700	$6.00	$154,200.00	12,859,119
1/13/2023	John Mendlein	Director	Buy	36,631	$5.43	$198,906.33	282,770
1/11/2023	John Mendlein	Director	Buy	88,048	$5.67	$499,232.16	246,139
1/10/2023	Bahram Valamehr	Insider	Sell	10,917	$5.24	$57,205.08	168,917
1/10/2023	Cindy Tahl	General Counsel	Sell	11,553	$5.24	$60,537.72	177,598
1/10/2023	Edward J. Dulac, III	CFO	Sell	7,331	$5.24	$38,414.44	129,470
1/10/2023	J. Scott Wolchko	CEO	Sell	45,907	$5.24	$240,552.68	385,639
8/18/2022	Edward J. Dulac, III	CFO	Sell	5,135	$29.81	$153,074.35	136,801
7/21/2022	J. Scott Wolchko	CEO	Sell	30,000	$32.88	$986,400.00	431,546
7/7/2022	Bahram Valamehr	Insider	Sell	17,158	$30.23	$518,686.34	179,834
7/5/2022	Mark Plavsic	Insider	Sell	3,719	$24.61	$91,524.59	127,123
6/7/2022	Shefali Agarwal	Director	Sell	841	$21.89	$18,409.49	1,840
6/3/2022	John Mendlein	Director	Sell	1,364	$22.79	$31,085.56	158,091
4/21/2022	J. Scott Wolchko	CEO	Sell	30,000	$35.00	$1,050,000.00	431,546
4/19/2022	Yu-Waye Chu	Insider	Sell	4,062	$35.37	$143,672.94	151,033
4/1/2022	Cindy Tahl	General Counsel	Sell	25,000	$38.85	$971,250.00	189,151
3/10/2022	John Mendlein	Director	Sell	31,562	$35.02	$1,105,301.24
1/20/2022	J. Scott Wolchko	CEO	Sell	30,000	$40.21	$1,206,300.00
1/11/2022	Edward J. Dulac, III	CFO	Sell	1,770	$48.45	$85,756.50
1/11/2022	Yu-Waye Chu	VP	Sell	3,965	$48.51	$192,342.15
1/10/2022	Bahram Valamehr	Insider	Sell	5,596	$46.38	$259,542.48
1/10/2022	Cindy Tahl	General Counsel	Sell	7,738	$46.43	$359,275.34
1/10/2022	J. Scott Wolchko	CEO	Sell	34,156	$46.86	$1,600,550.16
12/20/2021	Edward J. Dulac, III	CFO	Sell	15,977	$60.00	$958,620.00
12/13/2021	Bahram Valamehr	Insider	Sell	25,000	$47.66	$1,191,500.00
12/10/2021	Yu-Waye Chu	VP	Sell	7,500	$51.46	$385,950.00
11/18/2021	J. Scott Wolchko	CEO	Sell	20,000	$54.27	$1,085,400.00
10/21/2021	J. Scott Wolchko	CEO	Sell	30,000	$60.22	$1,806,600.00
10/1/2021	Cindy Tahl	General Counsel	Sell	50,000	$58.83	$2,941,500.00
9/28/2021	Edward J. Dulac, III	CFO	Sell	19,460	$62.53	$1,216,833.80
8/19/2021	Edward J. Dulac, III	CFO	Sell	3,474	$88.26	$306,615.24	56,076
8/19/2021	J. Scott Wolchko	CEO	Sell	20,000	$88.01	$1,760,200.00
7/22/2021	J. Scott Wolchko	CEO	Sell	30,000	$86.05	$2,581,500.00
6/14/2021	Bahram Valamehr	Insider	Sell	25,000	$89.32	$2,233,000.00	111,896

Biden replacement revealed?

From Paradigm Press | Ad

A former CIA insider just announced a disturbing prediction… Biden will withdraw as the Democrat nominee on June 13.

See his shocking evidence in this new report

SEC Filings (Institutional Ownership Changes) for Fate Therapeutics (NASDAQ:FATE)

97.54% of Fate Therapeutics stock is owned by institutions. Institutional ownership can be a sign of analyst confidence in the fundamentals of the stock.

Institutional Buying and Selling by Quarter

Fate Therapeutics Institutional Trading History

Reporting Date	Hedge Fund	Shares Held	Market Value	% of Portfolio	Quarterly Change in Shares	Ownership in Company
5/8/2024	Russell Investments Group Ltd.	110,248	$0.81M	0.0%	-52.8%	0.097%
5/7/2024	Susquehanna Fundamental Investments LLC	151,121	$1.11M	0.1%	N/A	0.133%
5/7/2024	SG Americas Securities LLC	37,456	$0.28M	0.0%	-58.6%	0.033%
5/1/2024	BNP Paribas Financial Markets	46,962	$0.35M	0.0%	+100.9%	0.041%
5/1/2024	Mirae Asset Global Investments Co. Ltd.	58,835	$0.43M	0.0%	N/A	0.052%
4/29/2024	Principal Financial Group Inc.	23,876	$0.18M	0.0%	-10.9%	0.021%
4/24/2024	Simplicity Wealth LLC	11,016	$81K	0.0%	N/A	0.010%
4/24/2024	Assenagon Asset Management S.A.	2,548,304	$18.71M	0.0%	+1,462.4%	2.239%
2/14/2024	Pennant Investors LP	146,100	$0.55M	0.1%	N/A	0.148%
2/14/2024	Superstring Capital Management LP	847,823	$3.17M	2.3%	N/A	0.860%
2/14/2024	Vestal Point Capital LP	1,290,000	$4.83M	0.5%	N/A	1.308%
2/13/2024	Tower Research Capital LLC TRC	15,233	$57K	0.0%	-62.7%	0.015%
2/12/2024	Bruce & Co. Inc.	143,000	$0.54M	0.2%	-28.5%	0.145%
2/12/2024	RPO LLC	12,307	$46K	0.1%	N/A	0.012%
2/8/2024	Panagora Asset Management Inc.	356,740	$1.33M	0.0%	-16.4%	0.362%
2/8/2024	Vanguard Personalized Indexing Management LLC	12,357	$46K	0.0%	-13.9%	0.013%
2/7/2024	Monaco Asset Management SAM	2,183,228	$8.17M	2.4%	+18.1%	2.214%
2/6/2024	National Bank of Canada FI	7,000	$26K	0.0%	-41.7%	0.007%
2/5/2024	Victory Capital Management Inc.	12,504	$47K	0.0%	+22.8%	0.013%
2/5/2024	Russell Investments Group Ltd.	233,748	$0.87M	0.0%	+34.0%	0.237%
1/31/2024	Knights of Columbus Asset Advisors LLC	32,184	$0.12M	0.0%	+100.0%	0.033%
1/31/2024	Federated Hermes Inc.	1,849,872	$6.92M	0.0%	-24.5%	1.876%
1/26/2024	Cerity Partners LLC	32,174	$0.12M	0.0%	N/A	0.033%
1/25/2024	Nisa Investment Advisors LLC	16,840	$63K	0.0%	+1,069.4%	0.017%
1/17/2024	Assenagon Asset Management S.A.	163,097	$0.61M	0.0%	-57.2%	0.165%
1/12/2024	SG Americas Securities LLC	90,553	$0.34M	0.0%	+23.0%	0.092%
1/11/2024	Epiq Partners LLC	10,071	$38K	0.0%	N/A	0.010%
1/5/2024	Exchange Traded Concepts LLC	63,725	$0.24M	0.0%	+34.0%	0.065%
12/19/2023	Public Employees Retirement System of Ohio	154,178	$0.33M	0.0%	+14.7%	0.156%
12/18/2023	Vanguard Group Inc.	10,908,351	$23.13M	0.0%	-7.0%	11.063%
11/17/2023	Jacobs Levy Equity Management Inc.	2,389,123	$5.07M	0.0%	+2.3%	2.423%
11/15/2023	Laurion Capital Management LP	35,173	$75K	0.0%	+128.6%	0.036%
11/13/2023	Algert Global LLC	91,864	$0.20M	0.0%	-82.9%	0.093%
11/13/2023	Federated Hermes Inc.	2,451,544	$5.20M	0.0%	-0.7%	2.486%
11/13/2023	Healthcare of Ontario Pension Plan Trust Fund	444,038	$0.94M	0.0%	-3.3%	0.450%
11/13/2023	Dark Forest Capital Management LP	425,901	$0.90M	0.1%	+477.9%	0.432%
11/13/2023	Acadian Asset Management LLC	2,149,597	$4.56M	0.0%	+135.5%	2.180%
11/13/2023	Hsbc Holdings PLC	110,392	$0.24M	0.0%	+212.3%	0.112%
11/13/2023	Aigen Investment Management LP	42,798	$91K	0.0%	N/A	0.043%
11/8/2023	State Board of Administration of Florida Retirement System	340,554	$0.72M	0.0%	+1,121.7%	0.346%
11/8/2023	Vanguard Personalized Indexing Management LLC	14,354	$30K	0.0%	N/A	0.015%
11/8/2023	Shell Asset Management Co.	77,199	$0.16M	0.0%	+1,962.5%	0.078%
11/7/2023	Quantbot Technologies LP	47,500	$0.10M	0.0%	+410.8%	0.048%
11/7/2023	Monaco Asset Management SAM	1,847,944	$3.92M	1.2%	+83.8%	1.875%
11/7/2023	Barclays PLC	118,751	$0.25M	0.0%	-75.2%	0.120%
11/7/2023	Fox Run Management L.L.C.	12,000	$25K	0.0%	N/A	0.012%
11/7/2023	Mitsubishi UFJ Kokusai Asset Management Co. Ltd.	60,299	$0.13M	0.0%	+15.1%	0.061%
11/6/2023	Assenagon Asset Management S.A.	380,737	$0.81M	0.0%	+281.3%	0.386%
10/31/2023	Panagora Asset Management Inc.	426,585	$0.90M	0.0%	+33.5%	0.433%
10/27/2023	TD Asset Management Inc	141,652	$0.30M	0.0%	+100.0%	0.144%
10/25/2023	Brown Advisory Inc.	19,364	$41K	0.0%	+53.3%	0.020%
10/24/2023	Bank of New York Mellon Corp	312,788	$0.66M	0.0%	-3.4%	0.317%
10/19/2023	Simplicity Solutions LLC	12,012	$25K	0.0%	N/A	0.012%
10/18/2023	Exchange Traded Concepts LLC	47,566	$0.10M	0.0%	+85.7%	0.048%
10/16/2023	Herbst Group LLC	15,700	$33K	0.0%	N/A	0.016%
10/13/2023	SG Americas Securities LLC	73,642	$0.16M	0.0%	N/A	0.075%
10/10/2023	National Bank of Canada FI	12,000	$25K	0.0%	N/A	0.012%
9/21/2023	Barclays PLC	479,099	$2.28M	0.0%	-4.3%	0.486%
8/15/2023	Capital Impact Advisors LLC	45,738	$0.22M	0.2%	+10.7%	0.046%
8/14/2023	Capital Fund Management S.A.	304,105	$1.45M	0.0%	+324.7%	0.309%
8/14/2023	Graham Capital Management L.P.	142,401	$0.68M	0.0%	N/A	0.144%
8/11/2023	Panagora Asset Management Inc.	319,487	$1.52M	0.0%	-1.8%	0.324%
8/11/2023	Trexquant Investment LP	333,986	$1.59M	0.0%	-8.6%	0.339%
8/11/2023	E Fund Management Co. Ltd.	51,350	$0.24M	0.0%	-35.1%	0.052%
8/10/2023	Profund Advisors LLC	171,261	$0.82M	0.0%	-32.8%	0.174%
8/10/2023	Jupiter Asset Management Ltd.	446,951	$2.12M	0.0%	+20.2%	0.454%
8/10/2023	Citigroup Inc.	1,075,649	$5.12M	0.0%	-4.4%	1.093%
8/9/2023	BNP Paribas Arbitrage SNC	509,803	$2.43M	0.0%	-29.9%	0.518%
8/9/2023	Mitsubishi UFJ Kokusai Asset Management Co. Ltd.	52,383	$0.25M	0.0%	+314.1%	0.053%
8/8/2023	Monaco Asset Management SAM	1,005,226	$4.79M	1.3%	+3.6%	1.022%
8/7/2023	Acadian Asset Management LLC	912,917	$4.34M	0.0%	N/A	0.928%
8/7/2023	Mirabella Financial Services LLP	13,467	$64K	0.0%	N/A	0.014%
8/3/2023	Barclays PLC	479,099	$2.28M	0.0%	-4.3%	0.487%
8/1/2023	Knights of Columbus Asset Advisors LLC	16,092	$77K	0.0%	-44.3%	0.016%
7/31/2023	Alpha DNA Investment Management LLC	147,651	$0.70M	0.2%	N/A	0.150%
7/31/2023	Brown Advisory Inc.	12,629	$60K	0.0%	N/A	0.013%
7/28/2023	Mach 1 Financial Group LLC	100,869	$0.48M	0.1%	N/A	0.103%
7/25/2023	Assenagon Asset Management S.A.	99,842	$0.48M	0.0%	N/A	0.101%
7/20/2023	Exchange Traded Concepts LLC	25,611	$0.12M	0.0%	-88.5%	0.026%
7/19/2023	Teacher Retirement System of Texas	21,303	$0.10M	0.0%	-11.0%	0.022%
7/18/2023	Diversified Trust Co	23,644	$0.11M	0.0%	+92.4%	0.024%
7/12/2023	Epiq Partners LLC	10,071	$48K	0.0%	N/A	0.010%
7/10/2023	AE Wealth Management LLC	100,885	$0.48M	0.0%	N/A	0.103%
5/23/2023	Capital Impact Advisors LLC	41,317	$0.24M	0.3%	+123.9%	0.042%
5/16/2023	Baker BROS. Advisors LP	1,671,717	$9.53M	0.1%	+675.0%	1.699%
5/16/2023	Boxer Capital LLC	500,000	$2.85M	0.1%	-60.0%	0.508%
5/15/2023	GCM Grosvenor Holdings LLC	495,916	$2.83M	0.8%	-52.2%	0.504%
5/12/2023	Bruce & Co. Inc.	200,000	$1.14M	0.3%	+250.9%	0.203%
5/12/2023	Dark Forest Capital Management LP	15,531	$89K	0.0%	N/A	0.016%
5/12/2023	C M Bidwell & Associates Ltd.	24,608	$0.14M	0.1%	+18,976.0%	0.025%
5/12/2023	Panagora Asset Management Inc.	325,361	$1.86M	0.0%	+1.6%	0.331%
5/12/2023	Profund Advisors LLC	254,989	$1.45M	0.1%	+2,178.5%	0.259%
5/11/2023	Cornercap Investment Counsel Inc.	41,863	$0.24M	0.0%	N/A	0.043%
5/11/2023	ExodusPoint Capital Management LP	97,235	$0.55M	0.0%	-60.4%	0.099%
5/11/2023	Citigroup Inc.	1,124,908	$6.41M	0.0%	+474.8%	1.143%
5/11/2023	E Fund Management Co. Ltd.	79,137	$0.45M	0.0%	+254.0%	0.080%
5/10/2023	Pictet Asset Management SA	1,199,241	$6.84M	0.0%	-0.3%	1.219%
5/10/2023	Jupiter Asset Management Ltd.	371,795	$2.12M	0.0%	N/A	0.378%
5/9/2023	Parametrica Management Ltd	18,472	$0.11M	0.2%	-42.7%	0.019%
5/9/2023	Russell Investments Group Ltd.	172,090	$0.98M	0.0%	+32,431.2%	0.175%

Data available starting January 2016

Fate Therapeutics, Inc., a clinical-stage biopharmaceutical company, develops programmed cellular immunotherapies for cancer and immune disorders worldwide. The company's chimeric antigen receptor (CAR)-targeted NK and T-cell product candidates include FT576 to treat multiple myeloma, and FT522, to treat lymphoma and autoimmune disorders. Its CAR T-cell programs include FT819 to treat hematologic malignancies and solid tumors, and FT825 to treat solid tumors. The company has a collaboration and option agreement with Ono Pharmaceutical Co. Ltd. for the development and commercialization of off-the-shelf, iPSC-derived CAR T-cell product candidates for the treatment of cancer. Fate Therapeutics, Inc. was incorporated in 2007 and is headquartered in San Diego, California.

Today's Range

Now: $3.70

$3.58

$3.81

50 Day Range

MA: $6.16

$3.70

$8.35

52 Week Range

Now: $3.70

$1.63

$8.83

Volume

2,150,223 shs

Average Volume

2,801,152 shs

Market Capitalization

$421.12 million

P/E Ratio

N/A

Dividend Yield

N/A

Beta

1.8

Who are the company insiders with the largest holdings of Fate Therapeutics?: Fate Therapeutics' top insider investors include:
Redmile Group, Llc (Director)
J Scott Wolchko (CEO)
John Mendlein (Director)
Bahram Valamehr (Insider)
Cindy Tahl (General Counsel)
Yu-Waye Chu (Insider)
Edward J Dulac III (CFO)
Mark Plavsic (Insider)
Brian T Powl (Insider)
Yuan Xu (Director)
Shefali Agarwal (Director)
Learn More about top insider investors at Fate Therapeutics.
Who are the major institutional investors of Fate Therapeutics?: Fate Therapeutics' top institutional investors include:
Assenagon Asset Management S.A. — 2.24%
Susquehanna Fundamental Investments LLC — 0.13%
Russell Investments Group Ltd. — 0.10%
Mirae Asset Global Investments Co. Ltd. — 0.05%
BNP Paribas Financial Markets — 0.04%
SG Americas Securities LLC — 0.03%
Learn More about top institutional investors of Fate Therapeutics stock.
Which institutional investors are selling Fate Therapeutics stock?: Within the previous quarter, FATE stock was sold by these institutional investors:
Russell Investments Group Ltd.
SG Americas Securities LLC
Principal Financial Group Inc.
In the last year, company insiders that have sold Fate Therapeutics company stock include:
Redmile Group, Llc (Director)
J Scott Wolchko (CEO)
John Mendlein (Director)
Bahram Valamehr (Insider)
Cindy Tahl (General Counsel)
Yu-Waye Chu (Insider)
Learn More investors selling Fate Therapeutics stock.
Which institutional investors are buying Fate Therapeutics stock?: During the previous quarter, FATE stock was acquired by institutional investors including:
Assenagon Asset Management S.A.
Susquehanna Fundamental Investments LLC
Mirae Asset Global Investments Co. Ltd.
BNP Paribas Financial Markets
Simplicity Wealth LLC
Within the last year, these company insiders have bought Fate Therapeutics stock:
Redmile Group, Llc (Director)
J Scott Wolchko (CEO)
Learn More investors buying Fate Therapeutics stock.

Elon to Transform U.S. Economy?

From Porter & Company | Ad